Skip to Main Content

Author Details

Maria Amaya
University of Colorado School of Medicine
2018
15
8
PMIDPaper TitleJournal TitlePublished Year
37358260A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.Cancer Discov2023
37873284Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.bioRxiv2023
37185614Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse.Bone Marrow Transplant2023
37051756Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.Haematologica2023
34525179The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.Blood2022
35529292Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization.Case Rep Oncol2022
36194842Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.JCO Clin Cancer Inform2022
33028621The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG.Cancer Discov2021
34610123Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.Blood Adv2021
33375853The propriety of upgrading responses to venetoclaxâ¿¿+â¿¿azacitidine in newly diagnosed patients with acute myeloid leukemia.Leuk Lymphoma2021
32309823Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab.Drugs Today (Barc)2020
31974170Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.Cancer Discov2020
32822582Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells.Cell Stem Cell2020
31869416Venetoclax for AML: changing the treatment paradigm.Blood Adv2019
29769206Targeting the <i>IDH2</i> Pathway in Acute Myeloid Leukemia.Clin Cancer Res2018
  • 1 - 15 of 15

Recommended Authors

Nicola Long
Oregon Health and Science University
Career Start Year 2018
Number of shared co-authors 2
Curtis A Lachowiez
University of Texas MD Anderson Cancer Center
Career Start Year 2017
Number of shared co-authors 0
Veronique Litalien
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2016
Number of shared co-authors 0
Jessica Leonard
Oregon Health & Science University
Career Start Year 2015
Number of shared co-authors 2
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Career Start Year 2014
Number of shared co-authors 2
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2011
Number of shared co-authors 4
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Patricia Kropf
Novant Health Cancer Institute - Elizabeth
Career Start Year 2009
Number of shared co-authors 2
Uma Borate
The Ohio State University
Career Start Year 2008
Number of shared co-authors 2
Courtney D DiNardo
UT MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 1
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 0
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
Ronan Swords
Oregon Health and Science University
Career Start Year 2004
Number of shared co-authors 2
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 2
Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Career Start Year 2000
Number of shared co-authors 0
Emmanuel Raffoux
Universite Paris Diderot
Career Start Year 1998
Number of shared co-authors 0
Elie Traer
Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 4
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 2
Timothy S Pardee
Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard
Career Start Year 1995
Number of shared co-authors 0
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 2
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 2
Jorge Cortes
Georgia Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 3
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Richard M Stone
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 2
Herv?? Dombret
Institut de Recherche Saint-Louis, Universite de Paris
Career Start Year 1984
Number of shared co-authors 0
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Career Start Year 1982
Number of shared co-authors 1

Collaborators

Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 12
Veronica Clavijo Jordan
Harvard Medical School
Co-authored papers 10
Shanshan Pei
Zhejiang University Medical Center
Co-authored papers 9
Brett M Stevens
University of Colorado School of Medicine
Co-authored papers 9
Amanda Winters
University of Colorado School of Medicine
Co-authored papers 8
Mohammad Minhajuddin
University of Colorado School of Medicine
Co-authored papers 8
Clayton A Smith
University of Colorado, Aurora CO.
Co-authored papers 7
Diana Abbott
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Co-authored papers 5
Anagha Inguva
University of Colorado School of Medicine
Co-authored papers 5
Anna Krug
University of Colorado School of Medicine
Co-authored papers 4
Haobin Ye
Institute of Metabolism & Integrative Biology, Fudan University
Co-authored papers 4
Courtney L Jones
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Maura Gasparetto
University of Colorado School of Medicine
Co-authored papers 2
Rachel Culp-Hill
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Travis Nemkov
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Fabia Gamboni
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Brian Raught
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Biniam Adane
The Broad Institute of MIT and Harvard
Co-authored papers 1
James C Costello
University of Colorado Anschutz Medical Campus
Co-authored papers 1
James DeGregori
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Sarah Gehrke
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Antonio Jimeno
University of Colorado School of Medicine
Co-authored papers 1
Tonya Brunetti
Co-authored papers 1
Annika Gustafson
University of Colorado Denver
Co-authored papers 1
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Co-authored papers 1
Sweta B Patel
The University of Alabama at Birmingham School of Medicine
Co-authored papers 1
Release 1.2